Gestarelle

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Gestarelle

What is Gestarelle? An Overview

Gestarelle is a branded prenatal dietary supplement designed to provide comprehensive nutritional support for women across the entire reproductive timeline: pre-conception, pregnancy, and lactation. It is sold over-the-counter (OTC) and belongs to the Pharmacological Class of combination vitamin and mineral supplements.

Property Description
Type/Status Branded OTC Prenatal Food Supplement
Key Active Ingredients Folic Acid (5-MTHF), Iron, Iodine, DHA (Omega-3)
Pharmacological Class Combination Vitamin/Mineral Supplement
Form/Route Soft Gel Capsule/Oral
General Purpose Nutritional support for maternal and fetal health

Key Ingredients and Differentiating Composition

The formulation focuses on high-quality, bioavailable forms of essential nutrients. This product often features active folate (5-MTHF) instead of standard folic acid, a form that is clinically recognized for optimal assimilation in all individuals. The supplement also includes well-tolerated Iron Bisglycinate and stabilized Omega-3 Fatty Acids (DHA) derived from purified fish oil.

Research highlights the importance of these core components in pregnancy. For instance, periconceptional folic acid supplementation is effective in preventing neural tube defects. Additionally, daily oral iron and folic acid supplementation can improve overall health outcomes.


Overall Therapeutic Role and Positioning

The therapeutic purpose of this product is to help optimize maternal nutrient stores and ensure the consistent supply of vitamins and minerals required for optimal fetal growth, particularly for the central nervous system. By targeting key nutritional deficiencies, such as those related to Iron and Iodine, the supplement acts as a valuable support measure during the increased metabolic demands of pregnancy and breastfeeding.

Regulatory References

  1. WHO Recommendations on Iron and Folic Acid Supplementation in Pregnancy

What side effects are possible with Gestarelle?

Possible side effects and safety information

This section outlines the officially documented adverse reactions and safety constraints for iron-containing prenatal multivitamins, such as Gestarelle, based on governmental regulatory sources.

Adverse Reaction Scope

Classification Examples (Organ Class: Gastrointestinal)
Common & Expected Constipation, nausea, abdominal discomfort, and diarrhea are frequently reported side effects. Stool discoloration (turning black or dark) is also common due to unabsorbed iron.
Time-Related Pattern Gastrointestinal side effects are often noted as transient, meaning they may be more prominent during the initial period of use as the body adjusts.

Serious Safety Considerations

Serious Adverse Reactions

  • Accidental Overdose: Regulatory bodies mandate a critical warning regarding iron-containing products. Accidental overdose of iron is a leading cause of fatal poisoning in children under 6 years of age. In case of suspected overdose, immediate emergency medical attention is required.
  • Allergic Reactions: Severe hypersensitivity reactions are rare but possible. Symptoms may include rash, swelling (of the face, tongue, or throat), severe dizziness, or trouble breathing.

Safety-Related Restrictions and Limitations

  • The product is generally contraindicated (should not be used) in patients with known iron overload disorders, such as hemochromatosis or hemosiderosis. Use in these conditions can lead to excessive iron accumulation and serious health consequences.
  • Caution is advised in individuals with certain types of anemia where high doses of folic acid could potentially mask signs of a Vitamin B12 deficiency.

Overdose and Emergency Response

Gestarelle is an iron-containing combination supplement. The official regulatory warnings for this type of product center on the acute toxicity risk of its iron component, which poses a serious concern in overexposure scenarios.

Documented Overdose Manifestations

Acute overdose may initially present as severe gastrointestinal distress, including persistent vomiting, diarrhea, abdominal pain, and potentially the vomiting of blood (hematemesis). Documented central nervous system effects include signs of lethargy and somnolence. Later manifestations can involve hypotension and rapid deterioration.


Life-Threatening Outcomes and Emergency Action

A severe overdose is associated with the risk of life-threatening systemic outcomes, including circulatory collapse, shock, hepatic failure (liver damage), and coma. Due to this severe risk, regulatory labeling mandates an immediate emergency action: the user must call a doctor or poison control center immediately upon any suspected accidental overdose. Immediate medical attention is required if the affected person has collapsed, had a seizure, or cannot be awakened.


Population Risk and Supportive Management

The regulatory profile explicitly identifies pediatric patients as a high-risk population, stating that accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six. Management of confirmed overdose involves symptomatic and supportive treatment, often requiring hospital monitoring and specialized interventions such as chelation therapy with Deferoxamine to address systemic iron toxicity.

Therapeutic Uses of Gestarelle

What Gestarelle Treats: Main Uses and Benefits

Gestarelle is commonly used to help with conditions associated with acute or disruptive episodes, specifically providing supportive nutritional benefits across the full spectrum of the reproductive cycle. It is relevant for use throughout the reproductive journey. It is recognized that obtaining specific nutrients daily, particularly before and during early pregnancy, is relevant for supporting healthy outcomes.

The primary therapeutic use is relevant in conditions associated with high physiological stress, specifically by contributing to adequate levels of Folate to assist with managing the risk of Neural Tube Defects (NTDs), such as Spina Bifida. It is also applied in clinical settings to address the symptoms of maternal tiredness and fatigue related to systemic imbalance. Furthermore, the provision of DHA and Iodine may assist with supporting the development of the fetal brain and eyes.

“The supplement is applied when appropriate in scenarios where additional management of discomfort is required due to the substantial nutrient requirements exceeding typical dietary intake.”

By providing essential micronutrients, the core benefit is to assist with maintaining maternal nutrient stores, which provides support that helps ease the overall symptom burden throughout the reproductive journey.

Quick Fact: Relief for Fatigue
Supports the management of tiredness and low energy associated with high metabolic demands and potential Iron deficiencies.

Eligibility and Restrictions for Use

Gestarelle is a prenatal supplement whose eligibility is defined by its intended use throughout the reproductive cycle and by mandated regulatory warnings related to its components.

Populations Explicitly Allowed

The product is explicitly permitted for adult women during the pre-conception, pregnancy, and lactation phases. Use is not established for pediatric or geriatric populations.


Populations Who Must Not Use Gestarelle

Use is strictly limited by the formulation's key ingredients:

  • Iron Overload Disorders: The supplement is absolutely contraindicated for individuals with conditions leading to systemic iron accumulation, such as hereditary hemochromatosis or hemosiderosis.
  • Pediatric Access: Children under 6 years of age must be strictly prohibited from accessing the supplement, as regulatory guidelines mandate a warning concerning the risk of fatal iron poisoning in this age group.
  • Hypersensitivity: Individuals with a documented allergy or known hypersensitivity to any component (including Iron, DHA, Iodine, or Folic Acid) must not use the product.

Use Requiring Caution

  • Vitamin B12 Deficiency: Caution is required for patients with undiagnosed or unmanaged pernicious anemia, as the folic acid component may mask the characteristic blood changes of the condition.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This product is a prenatal dietary supplement containing Iron and Folic Acid, and its official interaction profile is structured around the documented effects of these core components as outlined in regulatory documentation.

Officially Documented Interactions

Category Interacting Substances (Examples) Constraint/Requirement
Reduced Exposure of Co-administered Drug Quinolone Antibiotics (Ciprofloxacin), Tetracycline Antibiotics (Doxycycline), Thyroid Hormones (Levothyroxine), Bisphosphonates Requires Timing Separation of administration to prevent the iron from reducing the other medicine's absorption.
Drug-Food/Substance Absorption Interference Antacids, Dairy Products, Tea, Coffee Decreases the absorption of the supplement's iron component itself.
Pharmacodynamic/Therapeutic Conflict Folic Acid Antagonists (Methotrexate, Trimethoprim), Certain Anticonvulsants (Phenytoin) Requires Monitoring for reduced efficacy of the co-administered drug or for altered serum levels.

Specific Regulatory Constraints

The iron component's interaction with medicines like Ciprofloxacin mandates a minimum separation of 2 hours between the doses to mitigate the documented pharmacokinetic effect of reduced drug exposure. The Folic Acid component carries a formal caution that its use may mask the hematological symptoms of an underlying Vitamin B12 deficiency, a condition that requires monitoring to prevent neurological complications.

Mechanism of Action

Mechanism of Cellular Division and Metabolic Support

This domain focuses on the roles of 5-MTHF and Iron in contributing substrates and co-factors for high-rate biological processes. 5-MTHF acts as a direct methyl-donor and co-factor for the one-carbon metabolism cycle, which is essential for synthesizing the DNA and RNA building blocks required for rapid cell proliferation. Concurrently, Iron serves as the core substrate for Hemoglobin production, which is necessary for the oxygen-carrying capacity of the blood.


Structural and Signaling Integrity of the CNS

This cluster addresses the structural contribution of DHA and the hormonal control provided by Iodine. DHA is structurally integrated into the phospholipid bilayers of developing neuronal and retinal membranes, fundamentally altering membrane fluidity to promote synaptic signal transduction. Meanwhile, Iodine is the indispensable substrate for Thyroperoxidase (TPO) to synthesize T3 and T4 hormones, which are essential endocrine signals that modulate fetal neurodevelopment and overall metabolism.


Synergistic Physiological Capacity

The overall mechanism exhibits synergy between these components. 5-MTHF and Iron work together to facilitate red blood cell maturation, while DHA provides the material structure for the central nervous system, and the Iodine-derived hormones provide the signaling required to govern the organized growth of that structure. This combined approach modulates multiple, interdependent physiological pathways simultaneously.

Dosage and Administration Information

How to Use Gestarelle: Official Administration Guidelines

This section describes the official administration principles and procedures for Gestarelle, a prenatal nutritional supplement, as outlined in official product labeling. The information is strictly limited to the mechanics of use, dosage, and timing.


Dosage and Route of Administration

Gestarelle is administered orally as a Soft Gel Capsule. The official labeled dose is a fixed schedule of one capsule taken once daily. The capsule should be swallowed whole with a glass of water.


Usage Course and Timing

Course Duration

The established usage pattern for this supplement defines a long-term course that should be initiated from the time of wishing to conceive (pre-conception) and maintained throughout the entire pregnancy and breastfeeding period.

Administration Timing

To ensure proper intake conditions, the capsule must be taken with a meal, most commonly specified for intake in the middle of the lunchtime meal.


Special Procedural Condition

Official instructions include a critical procedural constraint regarding co-administered medications: if the user is taking Levothyroxine, a thyroid medication, the Gestarelle capsule must be taken at a separation of more than 2 hours from the Levothyroxine dose. This instruction defines a specific, required timing adjustment for proper use.


This protocol defines the standardized, continuous administration of the fixed daily dose across the entire reproductive timeline.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Gestarelle

Gestarelle is a combination prenatal supplement, and the research evidence supporting its use is primarily drawn from the extensive scientific literature exploring its key active components (Folate/5-MTHF, Iron, Iodine, and DHA) within the context of maternal and fetal health. Studies focus on monitoring physiological strain or stress during the reproductive cycle and assessing outcomes related to systemic or functional imbalance.


Evidence for Nutritional Support in Preventing Neural Tube Defects

This section summarizes the large body of evidence, including systematic reviews and meta-analyses of trials, that evaluated the role of the Folate component during the pre-conception and early pregnancy period to explore the association with Neural Tube Defects (NTDs). Researchers evaluating the incidence of NTDs (such as Spina Bifida) as a primary endpoint.

The findings describe patterns observed in the studies that contribute to the research basis for periconceptional folate supplementation, which is acknowledged in statements developed by major health organizations. Long-term outcomes for the specific bioavailable form (5-MTHF) have not been fully established in comparison to other forms of folate, as many large-scale prevention studies used different formulations.

Evidence for Supporting Maternal Energy and Iron Status

This section will outline the structure of the available Randomized Controlled Trials (RCTs) and physiological studies that focused on the Iron and Folate components, describing how researchers measured changes in hematological biomarkers and self-reported fatigue levels. Studies explored the use of these components in research contexts involving fluctuating or unstable symptoms.

Data show patterns related to lower rates of iron-deficiency anemia near term in women who received this nutritional support. Some trials also described subsequent changes in self-reported fatigue scores that were measured concurrently with a change in iron status. Research gaps exist in characterizing the specific contribution of the Iron component when compared against the effect of the multi-nutrient formula on subjective tiredness in non-anemic women.

Evidence for Fetal Brain and Eye Development Support

Research examined the DHA and Iodine components in studies evaluating daily-life functioning and outcomes reflecting daily functioning or activity level in the child. Study designs include meta-analyses of RCTs and observational cohort studies, which monitored pregnant and lactating women. Key outcomes monitored were the child's visual acuity and various neurodevelopmental assessment scores. Findings describe patterns observed in the studies, including observations of improved scores on some measures of infant visual acuity that were associated with maternal supplementation. However, findings regarding long-term cognitive outcomes often displayed variability across different trials, meaning certainty remains low in this specific area.

What Remains Uncertain and Areas for Future Research

This concluding section synthesizes the identified evidence gaps. Comparative evidence is lacking for how the specific bioavailable forms, such as 5-MTHF (folate) and Iron Bisglycinate, compare directly to other forms of these nutrients across all measured outcomes. Long-term effects are not fully established for many aspects of maternal health after the supplementation period ends. Research is ongoing in these areas to contribute to the broader evidence landscape.

Frequently Asked Questions (FAQ)

Common questions about Gestarelle (FAQ)


Q: What is the difference between Gestarelle and other common vitamins?

Official information identifies Gestarelle as a prenatal dietary supplement. It is specifically formulated to provide nutritional support during the reproductive cycle, covering pre-conception, pregnancy, and lactation. This formulation is distinct from general adult vitamins as it includes specialized components like 5-MTHF (active folate), DHA, and Iron Bisglycinate.


Q: Can you take Gestarelle if you are already taking other supplements?

Official warnings indicate that caution is advised when combining supplements, particularly because the folic acid component may potentially mask the signs of an underlying Vitamin B12 deficiency. For these reasons, consultation with a healthcare professional is recommended to evaluate the potential risk of cumulative effects with other products containing similar nutrients like iron or folate.


Q: Are headaches a common side effect of Gestarelle?

According to the official product safety information, headaches are not listed among the common and expected adverse reactions. The most frequently reported side effects are generally gastrointestinal in nature, including nausea, constipation, abdominal discomfort, and dark stool discoloration, which is expected due to the unabsorbed iron component.


Q: Can Gestarelle affect birth control pills?

The official regulatory profile identifies specific classes of medications, such as certain antibiotics and thyroid hormones, that require a timing separation from the supplement due to potential absorption interference from the iron. However, hormonal birth control pills are not specifically listed among the substances that officially require timing separation in the documented interaction profile.


Q: Why do official documents emphasize a certain time of day for taking Gestarelle?

Official instructions recommend taking the capsule with a meal to optimize the conditions for administration. This practice is primarily intended to support the proper intake of the components and help minimize the possibility of common gastrointestinal side effects, such as nausea or abdominal discomfort, which may occur with iron and fatty acid supplementation.


Q: Is Gestarelle safe for people with thyroid issues?

Due to the presence of Iodine, specific caution is mandated in official materials, particularly for those on thyroid medication. For patients taking Levothyroxine, regulatory constraints specify that the supplement must be administered at least 2 hours away from the medication dose. This timing is necessary to avoid the iron in the supplement from interfering with the absorption of the thyroid drug.


Q: Is there a general consensus on how effective Gestarelle is?

Official research summaries indicate that the evidence strongly supports the role of individual components, such as folate for aiding in the prevention of neural tube defects and iron for improving maternal iron status. However, official documents note that the certainty of evidence remains low for certain specific long-term outcomes, like fetal cognitive function.


Q: Why is Gestarelle sometimes described as 'essential' for certain conditions?

The components in the supplement are described in official documents as providing substrates for processes that are critical to rapid growth and development. For instance, 5-MTHF acts as a necessary co-factor for the creation of DNA building blocks during cell proliferation, and Iodine is required for the synthesis of thyroid hormones that modulate fetal neurodevelopment.


Q: How does Gestarelle compare to an over-the-counter multivitamin?

The official labeling classifies this product as a prenatal dietary supplement, meaning it is formulated specifically for the distinct nutritional requirements of the pre-conception, pregnancy, and lactation phases. Unlike a general multivitamin, this product contains stabilized DHA and forms of iron and folate (5-MTHF) that are noted to be important for fetal central nervous system and red blood cell development.


Q: Can men use Gestarelle for any reason?

According to official product eligibility guidelines, the supplement is explicitly permitted for adult women throughout the pre-conception, pregnancy, and lactation phases. The product is not formulated or clinically established for use by men or other populations outside of the labeled use.


Q: What does the term 'contraindication' mean for Gestarelle?

The term 'contraindication' in the official documentation specifies medical conditions under which the product must be strictly avoided. For this supplement, this includes systemic iron accumulation disorders, such as hemochromatosis, or a known hypersensitivity to any component. Using the supplement when contraindicated is associated with the risk of serious health consequences.


Q: Does taking Gestarelle require any special dietary changes?

Official instructions do not mandate following a specific therapeutic diet while taking the supplement. However, the label information does specify a procedural constraint: the supplement should be taken separately from substances like antacids, dairy products, tea, and coffee, as these can significantly reduce the absorption of the iron component.


Q: Is Gestarelle available in different forms (capsules, liquid, etc.)?

According to the official administration guidelines, the product is marketed and labeled exclusively as a Soft Gel Capsule for oral use. No alternative forms, such as liquids or chewable tablets, are referenced in the official product information.


Q: Why do official sources list so many potential interactions?

Regulatory agencies mandate that all documented pharmacokinetic effects of a product's active ingredients must be listed. The number of interactions is mainly due to the iron component, which is known to interfere with the absorption of many medications, making timing separation necessary when co-administering certain drugs.


Q: Is it true that taking Gestarelle can change the color of urine?

Official safety information indicates that a change in stool color (turning black or dark) is a common and expected side effect, which is attributed to the presence of unabsorbed iron. However, a change in the color of urine is not listed among the commonly reported effects documented for this supplement.


Q: Why is professional guidance recommended before starting Gestarelle?

Professional guidance is advised due to important safety constraints documented in the official label. The folic acid component can potentially mask the characteristic blood changes of an underlying Vitamin B12 deficiency. Furthermore, because the product is strictly contraindicated for individuals with existing iron overload disorders, consultation is recommended prior to use.


Q: What types of drug-drug interactions are considered high risk for Gestarelle?

Regulatory constraints identify several high-risk drug-drug interactions that primarily stem from the iron component. To prevent the iron from potentially reducing the efficacy of other medicines, the official label specifies that a minimum separation of 2 hours is necessary for co-administered drugs such as Levothyroxine (a thyroid hormone) and certain classes of antibiotics (like Quinolones).


Q: If I forget to take Gestarelle at lunchtime, can I take it later in the day?

The core constraint from the official administration guidelines is that the capsule is to be taken with a meal. If the typical lunchtime schedule is missed, it is generally taken later with another meal, such as dinner, consistent with official instructions. The critical constraint of maintaining a separation of at least 2 hours from any dose of Levothyroxine remains necessary if that medication is being taken.

How should Gestarelle be stored and disposed of?

Gestarelle is a dietary supplement, and its storage and disposal instructions are derived from mandatory labeling rules enforced by regulatory authorities to ensure product quality and consumer safety.

Storage Conditions

Official instructions require the product to be stored in a dry place at room temperature, while being protected from heat and direct light. Maintaining the supplement in its original packaging ensures protection against environmental stressors that could compromise the stability of the capsules.

Storage Requirement Specification
Temperature Protect from heat
Environment Dry place, protected from light
Safety Rule Keep out of the sight and reach of children

Disposal

The product must not be consumed after the printed expiration date. Unused or expired capsules must be disposed of according to local regulations. Consumers must avoid discarding the supplement into household wastewater or regular trash unless explicitly permitted by local waste management guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Gestarelle found in:

A-Z Index: